Clearmind Medicine Inc. (CMND) NASDAQ

1.01

-0.02(-1.94%)

Updated at September 08 04:00PM

Currency In USD

Clearmind Medicine Inc.

Address

1220 West 6th Avenue

Vancouver, BC V6H 1A5

Canada

Phone

604 260 1566

Sector

Healthcare

Industry

Biotechnology

Employees

4

First IPO Date

November 15, 2022

Key Executives

NameTitlePayYear Born
Dr. Adi Zuloff-Shani Ph.D.Chief Executive Officer01969
Ms. Mylene TouboulAccounting Manager0N/A
Ms. Adi VaronController0N/A
Prof. Mark Haden M.S.W.Vice President of Business Development01955
Mr. Alan Mark Rootenberg B.Com., B.Comm, C.A., CPAChief Financial Officer01952

Description

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.